Loading clinical trials...

Clareon IOL Retrospective Data Collection | Clinical Trials | Clareo Health

COMPLETED

Clareon IOL Retrospective Data Collection

Post Market Clinical Follow-up (PMCF) Pilot Study for the Clareon UVA IOLs Using Retrospective Data Collection From the WaveTec AnalyzOR Database

NCT05796674•Alcon Research

View on ClinicalTrials.gov

Summary

The purpose of this study is to provide real world evidence (RWE) on the performance of the Clareon ultraviolet absorbing (UVA) intraocular lenses (IOLs) to support the overall body of evidence on the Clareon IOL family.

Detailed Description

In this retrospective postmarket study, the WaveTec AnalyzOR Database will be reviewed. All available data that meet the data selection criteria as of the data cutoff will be analyzed.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Data Selection Criteria (eyes):
•Must have undergone cataract extraction by phacoemulsification with implantation of a Clareon UVA IOL (CC60WF, CCW0T3, CCW0T4, CCW0T5, CCW0T6, or CCA0T0) using the WaveTec ORA System.
•Must have a BCDVA in the WaveTec AnalyzOR Database from ≥ 10 days after surgery.
•Predicted residual refractive error spherical equivalent (SE) ≤ 0.75 D.

Locations (1)

Alcon Research, LLC

Fort Worth, Texas, United States

Key Dates

Start Date

August 18, 2023

Primary Completion Date

September 12, 2023

Completion Date

September 12, 2023

Last Updated

October 18, 2023

Enrollment

1,090

ACTUAL participants

Conditions

AphakiaAstigmatism

Interventions

Clareon UVA IOL

DEVICE

WaveTec Optiwave Refractive Analysis (ORA) System

DEVICE

Cataract surgery

PROCEDURE

Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery

NCT07078799

MyopiaAstigmatism

View study

RECRUITING

Clinical Evaluation of WaveLight Plus LASIK

NCT07127757

MyopiaAstigmatism

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 18, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clareon IOL Retrospective Data Collection

Inclusion Criteria

Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery

Clinical Evaluation of WaveLight Plus LASIK

A Three-Phase Contralateral Comparison of Ray-Tracing Guided LASIK Versus Three Other Refractive Surgery Platforms to Correct Myopia or Myopia With Astigmatism

Patient Reported Outcomes With WaveLight Plus LASIK

Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric

The Objective of This Study is to Evaluate the Perfomance of a Photorefraction Device for Screening Ametropia in Children. Eligible Participants Will Undergo Multiple Refractive Error Measurements, Visual Acuity and Strabismus Assessments During a Single Evaluation Visit.